Argentum Pharmaceuticals and Bausch Health Settle Patent Dispute Over JUBLIA®
NEW YORK, Jan. 13, 2021 /PRNewswire/ — Argentum Pharmaceuticals LLC, a generic pharmaceutical company, announced that it has reached a settlement agreement with Bausch Health US, LLC and Kaken Pharmaceutical Co., LTD., related to Argentum’s inter partes review petition challenging an…
Comments Off on Argentum Pharmaceuticals and Bausch Health Settle Patent Dispute Over JUBLIA®